
Former 23andMe CEO Outbids Big Pharma to Regain Control of DNA Testing Firm
Former 23andMe CEO Anne Wojcicki is set to regain control of the genetic testing firm she led to bankruptcy after outbidding a pharmaceutical company at an auction. The sale came on Monday after a nonprofit headed by Wojcicki, TTAM Research Institute, bid …